Nanosonics Ltd

  • IPO date: 2007-05-15
  • Sector: Healthcare
  • GIC Group: Health Care Equipment & Services
  • Industry: Medical Instruments & Supplies
  • Company website

Company description

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Financial highlights

Market Capitalization$1258.4445 million
P/E Ratio64.09
P/E Growth Ratio0
Book Value0.542
Dividend Per Share0
Earnings Per Share0.06
EBITDA21,944
Profit Margin0.1198
Operating Margin TTM0.1072
Return on Assets TTM0.0546
Return on Equity TTM0.1314
Revenue TTM165,992.992

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2005-06-30 1,260 777
2006-06-30 1,366
2007-06-30 8.424 8.424 8,728.874
2008-06-30 1,112 10,443
2009-06-30 309 121 188 10,705
2010-06-30 763 284 479 10,366
2011-06-30 2,247 981 1,266 15,249
2012-06-30 12,301 4,799 7,502 14,462
2013-06-30 14,899 6,428 8,471 17,423
2014-06-30 21,492 7,571 13,921 21,091
2015-06-30 22,214 6,901 15,313 24,387
2016-06-30 42,796 10,630 32,166 33,980
2017-06-30 67,507 17,352 50,155 39,307
2018-06-30 60,649 15,407 45,242 44,070
2019-06-30 84,585 21,508 63,077 51,320
2020-06-30 100,726 24,541 76,185 67,074
2021-06-30 101,834 22,695 79,139 75,185
2022-06-30 119,728 28,415 91,313 96,248
2023-06-30 167,515 35,348 132,167 121,304

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2005-06-30 1,533 2,273 3,014 2,810 2,001
2006-06-30 6,590 6,989 2,778 2,000 8,715
2007-06-30 31,906.432 33,396.993 2,079.782 40,998.01
2008-06-30 24,225 25,632 1,073 41,150
2009-06-30 13,881 17,582 1,270 41,425
2010-06-30 21,144 24,948 1,366 56,627
2011-06-30 12,356 16,848 2,542 58,138
2012-06-30 29,310 36,660 10,657 6 7,054 73,532
2013-06-30 24,064 33,653 11,946 6 7,565 74,068
2014-06-30 21,233 33,544 13,109 6 8,115 74,410
2015-06-30 45,724 60,365 15,689 8,700 11 103,059
2016-06-30 48,841 68,169 11,505 395 1,349 112,698
2017-06-30 62,989 99,256 12,005 404 946 112,713
2018-06-30 69,433 109,181 14,878 424 522 112,713
2019-06-30 72,180 129,521 19,438 445 76 112,713
2020-06-30 91,781 147,070 22,840 1,235 113,177
2021-06-30 96,027 162,304 26,736 1,479 113,539
2022-06-30 94,512 187,671 48,980 2,554 113,855
2023-06-30 112,159 219,920 56,060 2,882 114,211

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2005-06-30
2006-06-30 6,590.153
2007-06-30 -5,703.524 -4,586.396 25,316.279 6,590.153 31,906.432
2008-06-30 -7,147 -7,135 -7,682 31,907 24,225
2009-06-30 -8,754 -9,136 -10,344 24,225 13,881
2010-06-30 -8,172 -7,762 7,263 13,881 21,144
2011-06-30 -11,214 -9,001 -8,788 21,144 12,356
2012-06-30 -4,679 -5,029 16,954 12,356 29,310
2013-06-30 -5,768 -4,506 -5,246 29,310 24,064
2014-06-30 -2,605 -2,594 -2,831 24,064 21,233
2015-06-30 -5,460 -2,421 24,491 21,233 45,724
2016-06-30 122 3,224 3,117 45,724 48,841 0
2017-06-30 26,158 16,388 14,148 48,841 62,989 0
2018-06-30 5,751 9,009 6,444 62,989 69,433
2019-06-30 13,602 4,826 2,747 69,433 72,180
2020-06-30 10,137 22,812 19,601 72,180 91,781
2021-06-30 8,578 7,316 4,246 91,781 96,027
2022-06-30 3,742 9,469 -1,515 96,027 94,512
2023-06-30 19,883 23,314 17,647 94,512 112,159